Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Joseph Mulenga"'
Autor:
Dvora Leah Joseph Davey, Kristin M Wall, William Kilembe, Naw Htee Khu, Ilene Brill, Bellington Vwalika, Elwyn Chomba, Joseph Mulenga, Amanda Tichacek, Pamina M Gorbach, Susan Allen
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0189869 (2018)
IntroductionAttempts to conceive and pregnancy may increase HIV transmission to sex partners and infants. Our study evaluated the association between fertility intentions and HIV acquisition among Zambian HIV-serodiscordant couples.MethodsWe collecte
Externí odkaz:
https://doaj.org/article/3be3dbd6406b4e88b50087e3320b4893
Autor:
Kenneth C Kapembwa, Jason D Goldman, Shabir Lakhi, Yolan Banda, Kasonde Bowa, Sten H Vermund, Joseph Mulenga, David Chama, Benjamin H Chi
Publikováno v:
Journal of Global Infectious Diseases, Vol 3, Iss 3, Pp 269-274 (2011)
Objectives : Epidemiologic data of HIV and viral hepatitis coinfection are needed in sub-Saharan Africa to guide health policy for hepatitis screening and optimized antiretroviral therapy (ART). Materials and Methods: We screened 323 HIV-infected, AR
Externí odkaz:
https://doaj.org/article/03c00570779747c8a7a31480ec3df157
Autor:
Eugene Ruzagira, Andrew Abaasa, Etienne Karita, Joseph Mulenga, William Kilembe, Susan Allen, Ubaldo Bahemuka, Agnes N Bwanika, Jonathan Levin, Matthew A Price, Anatoli Kamali
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105089 (2014)
ObjectivesTo investigate the effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda and determine its implications for HIV prevention and other clinical trials.MethodsVolunteers in a cross-sectional study t
Externí odkaz:
https://doaj.org/article/56923533471743ffb4e2af446ba39a6d
Autor:
Jessica L Prince, Daniel T Claiborne, Jonathan M Carlson, Malinda Schaefer, Tianwei Yu, Shabir Lahki, Heather A Prentice, Ling Yue, Sundaram A Vishwanathan, William Kilembe, Paul Goepfert, Matthew A Price, Jill Gilmour, Joseph Mulenga, Paul Farmer, Cynthia A Derdeyn, Jiaming Tang, David Heckerman, Richard A Kaslow, Susan A Allen, Eric Hunter
Publikováno v:
PLoS Pathogens, Vol 8, Iss 11, p e1003041 (2012)
Initial studies of 88 transmission pairs in the Zambia Emory HIV Research Project cohort demonstrated that the number of transmitted HLA-B associated polymorphisms in Gag, but not Nef, was negatively correlated to set point viral load (VL) in the new
Externí odkaz:
https://doaj.org/article/e3afbeff6ddc4c2cbe6300350121c942
Autor:
Wei Song, Dongning He, Ilene Brill, Rakhi Malhotra, Joseph Mulenga, Susan Allen, Eric Hunter, Jianming Tang, Richard A Kaslow
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23469 (2011)
BACKGROUND:Acquisition of human immunodeficiency virus type 1 (HIV-1) infection is mediated by a combination of characteristics of the infectious and the susceptible member of a transmission pair, including human behavioral and genetic factors, as we
Externí odkaz:
https://doaj.org/article/7a17b8a712174f7185b8748d15165331
Autor:
Jianming Tang, Rakhi Malhotra, Wei Song, Ilene Brill, Liangyuan Hu, Paul K Farmer, Joseph Mulenga, Susan Allen, Eric Hunter, Richard A Kaslow
Publikováno v:
PLoS ONE, Vol 5, Iss 3, p e9629 (2010)
During untreated, chronic HIV-1 infection, plasma viral load (VL) is a relatively stable quantitative trait that has clinical and epidemiological implications. Immunogenetic research has established various human genetic factors, especially human leu
Externí odkaz:
https://doaj.org/article/b8d6e603aacf4be3a3f9597d235834ac
Autor:
Rong Rong, Bing Li, Rebecca M Lynch, Richard E Haaland, Megan K Murphy, Joseph Mulenga, Susan A Allen, Abraham Pinter, George M Shaw, Eric Hunter, James E Robinson, S Gnanakaran, Cynthia A Derdeyn
Publikováno v:
PLoS Pathogens, Vol 5, Iss 9, p e1000594 (2009)
One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stage
Externí odkaz:
https://doaj.org/article/e0d802978da44632b351e897f96b9fe2
Autor:
Etienne Karita, Nzeera Ketter, Matt A Price, Kayitesi Kayitenkore, Pontiano Kaleebu, Annet Nanvubya, Omu Anzala, Walter Jaoko, Gaudensia Mutua, Eugene Ruzagira, Joseph Mulenga, Eduard J Sanders, Mary Mwangome, Susan Allen, Agnes Bwanika, Ubaldo Bahemuka, Ken Awuondo, Gloria Omosa, Bashir Farah, Pauli Amornkul, Josephine Birungi, Sarah Yates, Lisa Stoll-Johnson, Jill Gilmour, Gwynn Stevens, Erin Shutes, Olivier Manigart, Peter Hughes, Len Dally, Janet Scott, Wendy Stevens, Pat Fast, Anatoli Kamali
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4401 (2009)
Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory referenc
Externí odkaz:
https://doaj.org/article/37ce974a6aa54315aaa8f1f37f330050
Autor:
Richard E Haaland, Paulina A Hawkins, Jesus Salazar-Gonzalez, Amber Johnson, Amanda Tichacek, Etienne Karita, Olivier Manigart, Joseph Mulenga, Brandon F Keele, George M Shaw, Beatrice H Hahn, Susan A Allen, Cynthia A Derdeyn, Eric Hunter
Publikováno v:
PLoS Pathogens, Vol 5, Iss 1, p e1000274 (2009)
The HIV-1 epidemic in sub-Saharan Africa is driven largely by heterosexual transmission of non-subtype B viruses, of which subtypes C and A are predominant. Previous studies of subtype B and subtype C transmission pairs have suggested that a single v
Externí odkaz:
https://doaj.org/article/cd718ab0396f4bf491cbdcefb4764d41
Autor:
Wendy Stevens, Anatoli Kamali, Etienne Karita, Omu Anzala, Eduard J Sanders, Walter Jaoko, Pontiano Kaleebu, Joseph Mulenga, Len Dally, Pat Fast, Jill Gilmour, Bashir Farah, Josephine Birungi, Peter Hughes, Olivier Manigart, Gwynn Stevens, Sarah Yates, Helen Thomson, Andrea von Lieven, Marietta Krebs, Matt A Price, Lisa Stoll-Johnson, Nzeera Ketter
Publikováno v:
PLoS ONE, Vol 3, Iss 4, p e2043 (2008)
An understanding of the health of potential volunteers in Africa is essential for the safe and efficient conduct of clinical trials, particularly for trials of preventive technologies such as vaccines that enroll healthy individuals. Clinical safety
Externí odkaz:
https://doaj.org/article/848897e1986b43da924d99db0a5e4fc4